• Pesticide Drift: UAV vs. Knapsack Sprayers Using Rhodamine B

  2026-06-03

  This field study directly compares pesticide spray drift profiles between unmanned aerial vehicles (UAVs) and electric knapsack sprayers (EKS) using Rhodamine B as a fluorescent tracer. The research provides quantitative evidence that UAV spraying results in greater drift distances and deposition rates, offering essential data for environmental risk assessment and regulatory development.

• Glioma Organoid Models: Preserving Microenvironment for Drug

  2026-06-02

  The reference study presents a patient-derived glioma organoid model (GlioME) that retains the cellular and microenvironmental complexity of primary tumors. This approach enables more accurate personalized drug screening and immune cell viability assessment in vitro, representing a significant advancement for translational glioma research.

• Hypoxia Pathway Modulation Restricts Measles and Nipah Virus

  2026-06-02

  The referenced study demonstrates that pharmacological activation of the hypoxia response pathway, via prolyl-hydroxylase domain (PHD) enzyme inhibition, robustly restricts both measles and Nipah virus infections in vitro and ex vivo. This work highlights a novel host-directed antiviral strategy and provides a mechanistic basis for targeting metabolic pathways in antiviral research.

• SIRT1-Mediated Deacetylation of Plk2 Regulates Centriole Dup

  2026-06-01

  This study uncovers a key regulatory mechanism where histone deacetylase SIRT1 targets and destabilizes the centrosomal protein Plk2, thereby controlling centriole duplication. The findings link acetylation-dependent protein stability to cell cycle progression, offering mechanistic insight into epigenetic regulation in cancer and chromosomal stability.

• Bestatin (Ubenimex): Next-Gen Aminopeptidase Inhibition in T

  2026-06-01

  Bestatin (Ubenimex) has re-emerged as a pivotal tool in translational oncology, offering precise and selective inhibition of key aminopeptidases implicated in cancer progression and multidrug resistance (MDR). This article unpacks the mechanistic rationale, experimental best practices, and translational opportunities for leveraging Bestatin, drawing on contemporary evidence and advanced workflow strategies. We bridge the gap between bench and bedside, positioning APExBIO’s Bestatin as an essential component for next-generation cancer and protease pathway research.

• MMP7 Drives EMT and Liver Fibrosis via E-cadherin/β-Catenin

  2026-05-31

  This study establishes matrix metalloproteinase 7 (MMP7) as a central driver of epithelial–mesenchymal transition (EMT) and liver fibrosis in biliary atresia (BA) by mediating E-cadherin cleavage and activating β-catenin signaling. The findings provide mechanistic insight and highlight the E-cadherin/β-catenin axis as a promising therapeutic target for pediatric liver fibrosis.

• Reliable DNA Damage Detection Using γH2AX Kit (Mouse mAb/Red

  2026-05-30

  This article addresses real-world challenges in DNA double-strand break detection and genotoxicity assessment, focusing on the γH2AX DNA Damage Detection Kit (Mouse mAb/Red), SKU K2275. By exploring practical laboratory scenarios and recent literature, it demonstrates how this kit provides reproducible, high-sensitivity results for biomedical researchers. Evidence-backed guidance ensures optimal workflow integration and confidence in data-driven decisions.

• Hexetidine (NSC-17764): Advanced Workflows for Biofilm Inhib

  2026-05-29

  Hexetidine (NSC-17764) is a potent, broad-spectrum antimicrobial uniquely effective against both planktonic and biofilm-associated bacteria, including antibiotic-resistant strains. This article details experimental workflows, protocol optimizations, and troubleshooting strategies that empower researchers to maximize the efficacy of Hexetidine in oral infection and biofilm inhibition assays.

• RNA Clean and Concentrator Kit: Elevating RNA Purity for Mec

  2026-05-29

  Explore how the RNA Clean and Concentrator Kit advances RNA purification spin column workflows for mechanistic studies, with a deep dive into unique scientific insights and practical assay implications.

• Staurosporine: Applied Workflows for Cancer Research & Apopt

  2026-05-28

  Staurosporine is a gold-standard broad-spectrum serine/threonine protein kinase inhibitor, enabling researchers to dissect apoptosis, angiogenesis, and microenvironmental signaling in cancer models. This guide translates the latest experimental insights into actionable protocols, troubleshooting, and comparative strategies for maximizing Staurosporine’s impact in advanced cancer research.

• Nuclear cGAS Suppresses L1 Retrotransposition via CHK2-TRIM4

  2026-05-28

  This study uncovers a novel nuclear function of cGAS: restricting LINE-1 (L1) retrotransposition to preserve genome integrity. It describes a DNA damage-activated regulatory axis in which CHK2-mediated phosphorylation of cGAS promotes TRIM41-dependent degradation of ORF2p, providing mechanistic insight into genome stability and potential targets for radioprotection and cancer research.

• Energy Deficiency, ATG4B, and DNA Repair in AML Progression

  2026-05-27

  This study reveals a direct mechanistic link between cellular energy deficiency and impaired DNA repair in acute myeloid leukemia (AML), mediated by ATG4B nuclear translocation and inhibition of PRMT1-dependent MRE11 methylation. These findings clarify how metabolic stress drives genomic instability and leukemia progression, offering new targets for therapeutic intervention.

• Applied Angiotensin I: Workflows, Troubleshooting & RAS Insi

  2026-05-27

  Leverage the full translational power of Angiotensin I with advanced experimental workflows and troubleshooting strategies. This guide distills protocol enhancements, cross-domain applications, and the latest evidence to elevate cardiovascular and antihypertensive research using APExBIO’s high-purity decapeptide.

• Crystal Violet Staining Solution: Enhanced Nuclear Staining

  2026-05-26

  Crystal Violet Staining Solution delivers robust, high-contrast nuclear staining for cell-based assays, streamlining quantification and visualization. Discover how optimized protocols and troubleshooting tips unlock its full potential for advanced cell biology research.

• Ridaforolimus (Deforolimus): Applied mTOR Inhibition in Canc

  2026-05-26

  Ridaforolimus (Deforolimus, MK-8669) enables precise, nanomolar mTOR pathway inhibition across diverse cancer models, streamlining apoptosis and anti-angiogenesis assays. Its robust performance and compatibility with advanced AI-driven screening make it a standout tool for translational research.

452 records 16/31 page Previous Next First page 上5页 1617181920 下5页 Last page